(Q46514004)

English

Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial

scientific article published in June 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15920715

Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15920715

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15920715

4

object named as

Bruno Vellas

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

author name string

Serge Gauthier

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15920715

Jane Hecker

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15920715

Yikang Xu

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15920715

John R Ieni

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15920715

Elias M Schwam

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15920715

Donepezil MSAD Study Investigators Group

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15920715

language of work or name

0 references

publication date

1 June 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15920715

International Journal of Geriatric Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15920715

20

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15920715

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15920715

559-569

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15920715

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

21 January 2018

Economic evaluation of donepezil in moderate to severe Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

21 January 2018

Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

21 January 2018

Cholinergic deficits contribute to behavioral disturbance in patients with dementia

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

21 January 2018

Reliability of a Standardized Mini-Mental State Examination compared with the traditional Mini-Mental State Examination.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

21 January 2018

Severe impairment battery. A neuropsychological test for severely demented patients.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

21 January 2018

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

21 January 2018

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

21 January 2018

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

21 January 2018

Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of donepezil in Alzheimer's disease - results from a multinational trial.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of rivastigmine in subjects with moderately severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective loss of central cholinergic neurons in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholinergic markers in elderly patients with early signs of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effects of rivastigmine in moderately severe Alzheimer's disease: does early initiation of therapy offer sustained benefits?

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

The stress and psychological morbidity of the Alzheimer patient caregiver.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of institutionalization for people with dementia living at home with a carer

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

Memantine in moderate-to-severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional assessment staging (FAST) in Alzheimer's disease: reliability, validity, and ordinality.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective analysis of risk factors for nursing home placement of dementia patients

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1325

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/GPS.1325

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15920715

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15920715

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46514004&oldid=2115627853"